| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lucira Health, Inc. | Director | Stock Option (right to buy) | 59.5K | Jun 1, 2022 | Direct | ||
| Pulse Biosciences, Inc. | CFO & EVP Admin. and Finance | Stock Option (right to buy) | 51.9K | Dec 14, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ADGM | Aja Holdco, Inc. | Jul 31, 2024 | 0 | $0 | 3 | Aug 1, 2024 | Director |
| KRON | Kronos Bio, Inc. | Sep 15, 2023 | 0 | $0 | 3 | Sep 18, 2023 | Interim CFO |
| NKTR | NEKTAR THERAPEUTICS | Apr 17, 2023 | 0 | $0 | 3 | Apr 25, 2023 | Chief Financial Officer |
| ANEB | Anebulo Pharmaceuticals, Inc. | Mar 2, 2023 | 0 | $0 | 3 | Apr 4, 2023 | Acting Chief Financial Officer |
| LHDXQ | Lucira Health, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| PLSE | Pulse Biosciences, Inc. | Dec 14, 2021 | 1 | $0 | 4 | Feb 28, 2022 | CFO & EVP Admin. and Finance |